PROTAGENIC Trademark

Trademark Overview

On Tuesday, December 7, 2021, a trademark application was filed for PROTAGENIC with the United States Patent and Trademark Office. The USPTO has given the PROTAGENIC trademark a serial number of 97160442. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, February 12, 2024. This trademark is owned by Protagenic Therapeutics, Inc.. The PROTAGENIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of stress, PTSD, depression, anxiety, addiction, addiction withdrawal symptoms, brain functions, neuropsychiatric disorders, and neurodegenerative diseases
protagenic

General Information

Serial Number97160442
Word MarkPROTAGENIC
Filing DateTuesday, December 7, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, February 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of stress, PTSD, depression, anxiety, addiction, addiction withdrawal symptoms, brain functions, neuropsychiatric disorders, and neurodegenerative diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 13, 2021
Primary Code005
First Use Anywhere DateTuesday, August 29, 2023
First Use In Commerce DateTuesday, August 29, 2023

Trademark Owner History

Party NameProtagenic Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10010
Party NameProtagenic Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10010

Trademark Events

Event DateEvent Description
Friday, February 16, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, February 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, February 12, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, February 10, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, January 22, 2024USE AMENDMENT FILED
Saturday, February 10, 2024SOU EXTENSION 1 GRANTED
Thursday, November 16, 2023SOU EXTENSION 1 FILED
Saturday, February 10, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 22, 2024NOTICE OF REVIVAL - E-MAILED
Monday, January 22, 2024TEAS STATEMENT OF USE RECEIVED
Monday, January 22, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, January 22, 2024NOTICE OF REVIVAL - E-MAILED
Monday, January 22, 2024PETITION TO REVIVE-GRANTED
Monday, January 22, 2024TEAS PETITION TO REVIVE RECEIVED
Monday, December 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, February 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, February 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 20, 2022NON-FINAL ACTION E-MAILED
Tuesday, September 20, 2022NON-FINAL ACTION WRITTEN
Wednesday, September 14, 2022ASSIGNED TO EXAMINER
Monday, December 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 10, 2021NEW APPLICATION ENTERED

Related Keywords

protagenic addiction functions brain neuropsychiatric disorders diseases neurodegenerative symptoms withdrawal stress